An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
In accordance with our annual plan, the Office of Inspector General (OIG) assessed the United States Capitol Police (USCP or Department) Pre-screener Program to determine whether (1) the organizational structure and training for the program was the most efficient and effective, and (2) the Department complied with applicable policies and procedures as well as applicable laws, regulations, and best practices. Our scope included the Pre-screener Program organizational structure, training, and compliance with policies and procedures.
Compliance Examination on Women Media and Development, Under Fixed Price Award AID-294-F-15-00007, Women's Court Project, January 1 to December 31, 2017
We investigated an allegation that Secretary of the Interior David Bernhardt, when he was the Deputy Secretary, interfered with the U.S. Fish and Wildlife Service’s (FWS’) scientific process during an assessment of the effects of pesticides on endangered species. We investigated whether Secretary Bernhardt exceeded or abused his authority by influencing consultations between the FWS and the U.S. Environmental Protection Agency on the proposed registration or re-registration of three pesticides, and whether his involvement in the consultations violated his ethics pledge or Federal ethics regulations.We found that Secretary Bernhardt reviewed a draft FWS opinion on the potential biological effects one of the three pesticides could have on endangered species, and he instructed the FWS team developing the opinion to change its method for determining the potential effects. This change has delayed the completion of the opinion, but we found no evidence that Secretary Bernhardt exceeded or abused his authority or that his actions influenced or altered the findings of career FWS scientists. We also found no evidence that Secretary Bernhardt’s involvement in this matter violated his ethics pledge or Federal ethics regulations.On January 7, 2021, this report was corrected to remove an inaccurate footnote. This correction did not affect our findings.
We investigated an allegation that Douglas Domenech, Assistant Secretary for Insular and International Affairs, U.S. Department of the Interior (DOI), violated his Federal ethics pledge under Executive Order No. 13770 by meeting with an official from his former employer, the Texas Public Policy Foundation (TPPF), during the required 2-year recusal period following Domenech’s resignation from the TPPF.Although we did not find that Domenech violated his ethics pledge as alleged, we found that he did violate Federal ethics regulations that prohibit Federal employees for 1 year from participating with their former employers in particular matters involving specific parties. Domenech, who began working for the DOI in January 2017 as a special Government employee (SGE), arranged and held two meetings with a TPPF attorney in April 2017 about issues in litigation between DOI bureaus and the TPPF. Domenech had a duty to consider whether his involvement in these meetings would cause a reasonable person to question his impartiality, and his failure to make that determination violated the regulation.Domenech did not violate his ethics pledge, however, because he was an SGE when the meetings took place and thus was not required to sign the pledge at the time. He signed the pledge in September 2017, after he became a permanent DOI employee.
According to the Centers for Disease Control and Prevention (CDC), opioids were involved in more than 47,000 deaths in 2017, and opioid overdose deaths were 6 times higher in 2017 than in 1999. CDC has awarded funding to States to address the nonmedical use of prescription drugs and to address opioid overdoses. We are conducting a series of audits of States that have received CDC funding to enhance their prescription drug monitoring programs (PDMPs). We selected California for audit because it experienced a significant increase in the rate of drug overdose deaths during 2016 and 2017.